Survival in Very Preterm Infants: an International Comparison of 10 National Neonatal Networks

Total Page:16

File Type:pdf, Size:1020Kb

Survival in Very Preterm Infants: an International Comparison of 10 National Neonatal Networks Survival in Very Preterm Infants: Kjell Helenius, MD, a, b Gunnar Sjörs, MD, c Prakesh S. Shah, MD, Msc, d, e Neena Modi, MD, f Brian Reichman, MBChB, g Naho AnMorisaki, MD,International PhD, h Satoshi Kusuda, MD, i Kei Lui, MD, jComparison Brian A. Darlow, MD, k Dirk Bassler, MD, of MSc, l Stellan Håkansson, MD, c Mark Adams, MSc, l Maximo Vento, MD, PhD, m Franca Rusconi, MD, n Tetsuya Isayama, MD, e Shoo K. Lee, MBBS, 10PhD, d, e Liisa National Lehtonen, MD, a, b on behalf Neonatal of the International Network Networks for Evaluating Outcomes (iNeo) of Neonates OBJECTIVES: abstract To compare survival rates and age at death among very preterm infants in 10 METHODS: national and regional neonatal networks. ’ A cohort study of very preterm infants, born between 24 and 29 weeks gestation and weighing <1500 g, admitted to participating neonatal units between 2007 and 2013 in the International Network for Evaluating Outcomes of Neonates. Survival was compared by using standardized ratios (SRs) comparing survival in each network to the survival RESULTS: estimate of the whole population. Network populations differed with respect to rates of cesarean birth, exposure – to antenatal steroids and birth in nontertiary hospitals. Network SRs for survival were – highest in Japan (SR: 1.10; 99% confidence interval: 1.08 1.13) and lowest in Spain (SR: ’ – 0.88; 99% confidence interval: 0.85 0.90). The overall survival differed from 78% to 93% among networks, the difference being highest at 24 weeks gestation (range 35% 84%). – ’ Survival rates increased and differences between networks diminished with increasing gestational age (GA) (range 92% 98% at 29 weeks gestation); yet, relative differences in survival followed a similar pattern at all GAs. The median age at death varied from 4 days CONCLUSIONS: to 13 days across networks. The network ranking of survival rates for very preterm infants remained largely unchanged as GA increased; however, survival rates showed marked variations at lower GAs. The median age at death also varied among networks. These findings warrant further assessment of the representativeness of the study populations, organization of perinatal services, national guidelines, philosophy of care at extreme GAs, and resources used for decision-making. WHAT’S KNOWN ON THIS SUBJECT: Survival rates of aDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital, Kiinamyllynkatu, Turku, Finland; very preterm infants vary among regions. International bDepartment of Clinical Medicine, University of Turku, Turku, Finland; cNational Quality Registry for Neonatal collaborations have been established to compare Care, Department of Pediatrics/Neonatal Services, University Hospital of Umeå, Umeå, Sweden; dDepartment of Pediatrics, University of Toronto, Toronto, Ontario, Canada; eMaternal-Infant Care Research Centre, outcomes, but population-based comparisons have and Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada; fUnited Kingdom Neonatal been difficult to accomplish. Collaborative, Neonatal Data Analysis Unit, and Section of Neonatal Medicine, Department of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom; gGertner Institute for Epidemiology WHAT THIS STUDY ADDS: This study shows variations in and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel; hDepartment of Social Medicine, survival and age at death among very preterm infants National Center for Child Health and Development, Tokyo, Japan iMaternal and Perinatal Center, Tokyo Women’s in 10 national neonatal networks and provides insight Medical University, Tokyo, Japan; jRoyal Hospital for Women, and National Perinatal Epidemiology and Statistics into differences that affect comparisons. The findings k Unit, University of New South Wales, Randwick, Australia; Department of Pediatrics, University of Otago, warrant investigation of the organization of perinatal Christchurch, New Zealand; lDepartment of Neonatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; mHealth Research Institute La Fe, Avenida Fernando Abril Martorell, Valencia, Spain; and nTIN care in participating networks. Toscane Online, Unit of Epidemiology, Meyer Children’s University Hospital, Florence, Italy and Regional Health Agency of Tuscany, Florence, Italy To cite: Helenius K, Sjörs G, Shah PS, et al. Survival in Very Preterm Infants: An International Comparison of 10 National Neonatal Networks. Pediatrics. 2017;140(6):e20171264 Downloaded from www.aappublications.org/news by guest on September 23, 2021 PEDIATRICS Volume 140, number 6, December 2017:e20171264 ARTICLE Helenius et al 2017 ROUGH GALLEY PROOF Survival in Very Preterm Infants: An https://doi.org/10.1542/peds.2017-1264 December 2017 International Comparison of 10 National Neonatal Networks 6 140 Pediatrics METHODS Preterm birth remains the major Population and Study Design however, a number of neonatal units cause of infant mortality1 in high- have not consented for participation income countries. Studies published in iNeo. Covariates in the last decade have shown ’ This cohort study included infants variability in survival rates and – born at 24 to 29 weeks gestation, outcomes among health care settings 2 12 weighing <1500 g at birth, and as well as within countries. GA was determined by the best registered in participating network Results from the Euro-Peristat – – estimate based on either early databases from 2007 to 2013 project showed that neonatal ultrasound, the timing of the last (2008 2013 for UKNC, 2009 2013 survival among very preterm infants menstrual period, or physical for TuscanNN). The criterion of 1500 g improved by 29% between 2004 examination after birth, in that order. was used because some networks and 2010 in 18 European countries, Antenatal steroid use was defined as limited their data collection to including those with high baseline maternal receipt of antenatal steroids 13 infants with a birth weight <1500 g. z survival. Such comparisons of at any time before birth. Birth weight Stillborn infants and delivery room different health care organizations scores were calculated according to deaths were not included because – worldwide can deliver important birth weight references appropriate all networks do not routinely collect 15 17 benchmarking information and for each country. Mode of data on these infants. Because potentially provide impetus for delivery was recorded as vaginal or of variability in practices and reviewing clinical practices, norms, ’ cesarean. Multiple births included philosophy of care provision at and guidelines. ≥ ’ twins and higher-order multiples. <24 weeks GA, we only included Outcomes The International Network for neonates born at 24 weeks gestation. Infants admitted for the Evaluating Outcomes of Neonates ’ (iNeo) is a nonprofit collaboration first time to neonatal care after 36 The primary outcome was survival among 10 national and regional weeks corrected GA were excluded. to discharge from the hospital for neonatal networks: the Australian Data on infant characteristics infants admitted to neonatal care. and New Zealand Neonatal Network and outcomes were extracted, as 14 Survival to transfer to a step-down (ANZNN), the Canadian Neonatal previously described. Transferred hospital was used when follow-up Network (CNN), the Finnish Medical infants were included only once. was available only until the transfer. Birth Register (FinMBR), the Israel Population coverage of networks We analyzed survival in 1-week GA Neonatal Network (INN), Neonatal deviate from national birth statistics increments. As a secondary outcome, Research Network Japan (NRNJ), ’ for various reasons. All neonatal we compared postnatal age at death the Spanish Neonatal Network units in Finland, New Zealand, and among nonsurvivors. Neonatal (SEN1500), Sweden s National Tuscany participate in their national morbidities among iNeo survivors Quality Registry for Neonatal Care 18 and regional neonatal networks; have been recently published. (SNQ), the Swiss Neonatal Network Data Management however, in Australia, apart from (SwissNeoNet), Tuscany Neonatal all tertiary neonatal units, only a Network (TuscanNN), and the United few lower-level units participate in Kingdom Neonatal Collaborative the ANZNN. In Canada, only tertiary For most networks, defined data (UKNC). The overarching aim of the neonatal units participate in the elements were either collected iNeo collaboration is to compare CNN. In Israel, all neonatal units from patient records by designated outcomes of very preterm infants, participate, but infants with a birth abstractors according to network understand reasons for variations, weight >1500 g are not included. policies or entered directly and, if possible, identify areas for In Japan and Spain, not all neonatal into a central online database improvement in care practices based 14 units participate in the national by participating units. For the on findings. networks. In Sweden, all neonatal UKNC, data were obtained from å By using the iNeo data set, the units presently participate in the the National Neonatal Research objective of this study was to SNQ; however, the Sk ne region is Database managed by the Neonatal compare gestational age (GA)-specific not included in this study because Data Analysis Unit, which contains survival rates for very preterm it joined in 2011. In Switzerland, all a predefined extract from electronic infants in all neonatal networks tertiary and large secondary
Recommended publications
  • 0201 Haplotype on the Risk for Multiple Sclerosis in Diverse Arab Populations in Israel
    Genes and Immunity (2010) 11, 423–431 & 2010 Macmillan Publishers Limited All rights reserved 1466-4879/10 www.nature.com/gene ORIGINAL ARTICLE Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel G Benedek1,6, T Paperna2,6, N Avidan2, I Lejbkowicz2, JR Oksenberg3, J Wang3, C Brautbar1,4, S Israel4 and A Miller2,5, for the Israeli MS Genetics group7 1The Lautenberg Center for Immunology, Hebrew University Hadassah Medical School, Jerusalem, Israel; 2Faculty of Medicine, Rappaport Research Institute, Technion–Israel Institute of Technology, Haifa, Israel; 3Department of Neurology, University of California, San Francisco, CA, USA; 4Tissue Typing and Immunogenetics Unit, Hadassah Medical Center, Jerusalem, Israel and 5Division of Neuroimmunology and Multiple Sclerosis Center, Carmel Medical Center, Haifa, Israel Different multiple sclerosis (MS) prevalence rates were reported for Muslim and Christian Arabs in Israel. In this study, we evaluated whether associations of human leukocyte antigen (HLA) genes with MS may contribute to this prevalence difference. DNA samples from Israeli Arab MS patients (n ¼ 109) and controls (n ¼ 132) were typed for HLA class I (HLA-A, -B and -C) and II (HLA-DRB1 and -DQB1) genes. Global comparisons of HLA allele frequencies revealed significant differences between Christians and Muslims; therefore, case–control analyses were stratified by religious affiliation. Disease characteristics of Muslim and Christian Arab MS patients were similar to those reported for European populations. Opposing association signals with MS were observed for alleles composing the DRB1*0301-DQB1*0201 haplotype: positive association of the HLA- DRB1*0301 allele in Muslims (PBonferroni ¼ 0.004, odds ratio (OR) ¼ 3.07), and negative association in Christian Arabs (PBonferroni ¼ 0.01, OR ¼ 0.12), with similar results obtained for HLA-DQB1*0201.
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • Curriculum Vitae Shay Schneider, M.D
    April, 2020 Curriculum Vitae Shay Schneider, M.D Name: Shay Schneider Date of birth: December 23, 1979 Place of birth: Tel Aviv, Israel Family status: Married +2 Telephone: +972-54-7685189 E mail: [email protected] CLINICAL EXPERIENCE Sep 2018-present: Senior staff member Otolaryngology department, Soroka University Medical Center, Beer Sheva, Israel. Sep 2018-Sep 2020: Clinical Fellow (Rhinology and skull base surgery), A.R.M, Center of Otolaryngology/ Head and Neck Surgery, Assuta Medical Center, Tel Aviv, Israel. Sep 2012-Sep 2018: Resident: Otolaryngology department, Soroka University Medical Center, Beer Sheva, Israel. Jan 2011 - Jan 2012: Rotating internship year: Training physician in internal medicine, general surgery, anesthesia and pediatrics units, Barzilai Medical Center in Ashkelon, Israel. Jun 2009 - Aug 2009: Clinical rotation in Otolaryngology, Shaare Zedek Medical Center in Jerusalem, Israel. ACADEMIC DEGREES 2016- present: Instructor, Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel. 2004-2010: MD degree, Third Medical Faculty, Charles University in Prague (English program), Czech Republic. POST ACADEMIC COURSES Jan 2020: Baloon sinuplasty and Eustachian tuboplasty, Madeira, Portugal. Aug-Sep 2018: Observership, University of Texas MD Anderson Cancer Center, Houston, Texas. United States 2013-2018: School of Continuing Studies, Otolaryngology program, The Sackler Faculty of Medicine, Tel Aviv University, Israel. June 2017: Rhinoplasty course, Ziv Medical Center, Israel Feb 2017: 4th Annual OSAS International Surgery Course, Florida Hospital Nicholson Center & Florida Hospital Celebration Health, Celebration, United States. Feb 2017: Trans- oral laser surgery (TLS) course, Kaplan Medical Center. Sep 2016: Head and neck dissection course, Tel Aviv University. Oct 2014: Sedation course, Sheba Medical Center, Tel Aviv.
    [Show full text]
  • APF Newsletter, Winter 2006 – 2007
    Winter 2006-2007 APF A Newsletter of the From The President AmericanEmergency Physicians andFellowship Disaster Preparednessfor Medicine in Israel Course News in Israel From The President Israel in Crisis Mission August 2006 would like to share with our members and donors the important by Dr. Dan Moskowitz I APF activities of the past 6 months. his past August, I had the privilege of being invited to par- 1. APF ISRAEL CRISIS FUND REPORT After placing on our T ticipate in an Emergency APF Mission to Israel with APF website and sending a special crisis appeal from Dr. Danny Laor, Board members Drs. Mike Frogel, Paul Liebman and Charles the Deputy Minister for Emergency Preparedness, on the critical Kurtzer. Dr. Boaz Tadmor organized an incredible, whirlwind needs of the Northern hospitals, it was very gratifying indeed that over $100,000 tour for us, only two days after the cessation of hostilities in was received for our Crisis Fund. All of this will be distributed to hospitals such as Israel. We were provided with a unique glimpse of the Israeli Sieff Hospital in Safed, Poriya in Tiberias, Western Galilee Medical Center in Nahariya, and Rambam Medical Center in Haifa, with the hospital CEO’s given the healthcare system under stress, including face-to-face meet- discretion as to how best to utilize these funds to help their hospital in light of the ings with top healthcare officials, as well as visits to the trau- recent crisis. matized hospitals in northern Israel. Perhaps most importantly, we visited 2. MISSION TO ISRAEL Three APF Board members, Drs.
    [Show full text]
  • ERJ-02682-2020.Shareable
    ORIGINAL ARTICLE | LUNG CANCER Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals Mina Gaga 1, Joanna Chorostowska-Wynimko 2, Ildikó Horváth3, Martin C. Tammemagi4, David Shitrit5, Vered H. Eisenberg6, Hao Liang7, David Stav8, Dan Levy Faber9,10, Maarten Jansen11, Yael Raviv12, Vasileios Panagoulias13, Piotr Rudzinski2, Gabriel Izbicki14, Ohad Ronen 15, Adiv Goldhaber 16, Rawia Moalem17, Nadir Arber18, Ilana Haas19 and Qinghua Zhou 7 Affiliations: 17th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece. 2National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland. 3National Korányi Institute of Pulmonology, Budapest, Hungary. 4Brock University, St Catharines, ON, Canada. 5Pulmonary Dept, Meir Medical Center, Kfar Saba, Israel. 6Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 7Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, China. 8Lung Institute, Maccabi Health Services Hashalom, Tel-Aviv, Israel. 9Dept of Cardiothoracic Surgery, Lady Davis Carmel Medical Center, Haifa, Israel. 10Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel. 11Pulmonary Dept, Ziekenhuisgroep Twente, Hengelo, The Netherlands. 12Dept of Medicine, Pulmonology Institute, Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel. 132nd Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece. 14Pulmonary Institute, Shaare Zedek Medical Center, Jerusalem, Israel. 15Dept of Otolaryngology – Head and Neck Surgery, Galilee Medical Center affiliated with Azrieli Faculty of Medicine, Safed, Israel. 16Clalit Health Services, Raanana, Israel. 17Gastroenterology Institute, The Holy Family Hospital, Nazareth, Israel. 18Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Centre, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
    [Show full text]
  • December FIHS 2013
    NEWSLETTER OF THE FRIENDS of the Israel Heart Society new research from Israel and an article on Israeli efforts to help in the Philippines in the aftermath of the Storm. In this issue, meet Professor Yoseph Rozenman, the new President of the Israel Heart Society. We also include an interview with Dan Tzivoni, long time head of cardiology at Jerusalem’s Shaare Road to Jerusalem, December 2013 Zedek Hospital. Finally, in our Editor’s Note: Welcome to the FIHS Heart Beats section, instead Winter 2013 FIHS Newsletter. of featuring a book written by a Thanks for all of the excellent member of the society, we comments on our last double feature a book review of a book issue. We celebrate the written about a member of the convergence of 2 great holidays- society, the dean of American one is a thanksgiving victory cardiology- our Board Member celebration by the Jewish people Eugene Braunwald. in their first war for religious freedom. The second is the Please save the date- Come to Thanksgiving celebration of the our annual FIHS reception at pilgrims who arrived in America ACC- Sunday evening, march seeking their own religious 30. Details to be announced. freedom. For an excellent article Hope to see you in Washington connecting Chanukah and DC! Thanksgiving, please see Please note- description of new http://download.yutorah.org/2013/1053/Ch anuka_To-Go_-_5774_Rabbi_Soloveichik.pdf technology in our Newsletter does not constitute an This issue includes the usual endorsement. We just want to sections such as the President’s give our readership a sense of Message and announcement of the vast scope of Israeli FIHS is on the web at http://friendsihs.org/index.html.
    [Show full text]
  • A National Survey of Acute Cerebrovascular Disease in Israel: Burden, Management, Outcome and Adherence to Guidelines
    Original Articles A National Survey of Acute Cerebrovascular Disease in Israel: Burden, Management, Outcome and Adherence to Guidelines David Tanne MD1,4, Uri Goldbourt PhD4, Silvia Koton PhD2,4, Ehud Grossman MD3,4, Nira Koren-Morag PhD4, Manfred S. Green MD PhD2,4 and Natan M. Bornstein MD1,4 on behalf of the National Acute Stroke Israeli Survey Group* 1 Israel Neurological Association 2 Israel Center for Disease Control (ICDC), Ministry of Health, Tel Hashomer, Israel 3 Israel Society of Internal Medicine 4 Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel Key words: stroke, national registry, outcome Abstract In Israel, as in the United States and most European countries, Background: There are no national data on the burden and stroke is the third most common cause of death [1]. The main management of acute cerebrovascular disease in Israel. burden of stroke, however, is the severe long-term disability Objectives: To delineate the burden, characteristics, manage- associated with it. National data on the burden and manage- ment and outcomes of hospitalized patients with acute cerebro- ment of acute stroke in Israel are lacking. As the management vascular disease in Israel, and to examine adherence to current guidelines. of acute ischemic stroke advances, widespread implementation Methods: We prospectively performed a national survey in all of optimal stroke care continues to pose enormous challenges 28 hospitals in Israel admitting patients with acute cerebrovascular for healthcare systems. Clinical guidelines have been developed events (stroke or transient ischemic attacks) during February and to provide timely and appropriate decisions for patients admit- March 2004.
    [Show full text]
  • The Israel Multiple Sclerosis Society the IMSS Publishes in 4 Languages & All Provides Services to Persons with MS Services Are Provided in 4 Languages
    The Israel +972 - 3 - 53 77 002 Multiple Sclerosis Society [email protected] www.mssociety.org.il The Israel Multiple Sclerosis society The IMSS publishes in 4 languages & All provides services to persons with MS services are provided in 4 languages. belonging to the diverse sectors of The Society adapts its activities to population that make up the State of meet the various requirements and Israel: Hebrew, Arab, Russian, English customs of the various sectors & speaking persons. different minorities. The Israel MS society activities MS 27 multidisciplinary Support Peer adult groups counseling enrichment group 01 MS site resort 27 Support groups facilitated by Hotline professional psychologists & social 16 01 Society 15 workers in Hebrew, Arabic, Russian library 02 The support groups operate throughout the country. The groups meet once every two, three or four weeks 14 & some 30- 35 patients & family members participate in 03 Community each meeting. These meetings provide an opportunity Book listing social to relieve tensions, share problems & get advice & the rights of13 worker encouragement. MS patients 04 Russian language 8 12 social worker 02 Seminars & conferences 05 Peer counseling group Yearly in which patients who have had special training provide 11 telephone counseling to other patients. The counselors Grants 20 Social meet once a month for training. & loans 06 Work fund 10 07 students Legal 09 Data Coordinator 08 in Arabic 03 advice Yearly MS Hotline patients Yearly Excursions Summer run by a coordinator & specially trained operators, who camp handle incoming & outgoing calls to/from patients & & vacations members of their families. 04 Community social worker individual & community information & counseling, help 09 with referrals to government agencies, home visits.
    [Show full text]
  • Israeli Cardio-Oncology Society Virtual Meeting Preliminary Program
    January 13-14, 2021 | Virtual Conference TOWARDS A COMPREHENSIVE CARDIAC-CANCER CARE Take this unique opportunity to join the ISCO 2021 conference and to effectively reach hundreds of cardiologists, oncologists and hemato-oncologists. Join us and present your research and technology to this influential and knowledgeable audience, and to have full access to all networking benefits. Conference secretariat - Dirigo Events & Conferences 3 Menorat Hamaor st. Tel-Aviv, Israel For more information, please contact: Tel: 03-7775485 | Email: [email protected] Yael Ziv Project Manager – Industry Liaison, Dirigo | Mobile: +972-54-5599821 | Email: [email protected] ISRAELI CARDIO-ONCOLOGY SOCIETY VIRTUAL MEETING PRELIMINARY PROGRAM Platinum Sponsorship Gold Sponsorship Silver Sponsorship January 13, 2021 15:45-16:00 Opening Session 15:45-15:47 Zaza Iakobishvili, Founder and Chair of the Meeting, Cardiology 15:47-15:49 Dan Gilon, Chair of the Meeting, Cardiology 15:49-15:51 David Sarid, Chair of the Meeting, Oncology 15:51-15:53 Martin Ellis, Chair of the Meeting, Hematology 15:53-15:55 Alex Lyon, ESC Cardio-Oncology Council 15:55-15:57 Bonnie Ky, JACC Cardio-Oncology 16:00-17:00 Plenary Session Chairs: Giorgio Minnotti, Faculty of Medicine and Surgery, Campus Bio-Medico University of Rome, Italy Alexander Battler, Chairman, Advisory Council on Cardiovascular Disease Management and Prevention, Ministry of Health, Israel 16:00-16:20 How to establish Cardio-Oncology collaboration Susan F. Dent, Associate Director of Breast Cancer Clinical Research, Co-Director Duke Cardio-Oncology Program, Durham, NC, USA 16:20-16:40 Guidelines in Cardio-Oncology: Gaps and Opportunities José Luis Zamorano, University Hospital Ramon Y Cajal, Madrid, Spain 16:40-17:00 Panel discussion: Future of Cardio-Oncology Richard H.
    [Show full text]
  • Preventive Strategies and Factors Associated With
    Open access Original research BMJ Open: first published as 10.1136/bmjopen-2019-031086 on 14 October 2019. Downloaded from Preventive strategies and factors associated with surgically treated necrotising enterocolitis in extremely preterm infants: an international unit survey linked with retrospective cohort data analysis Mark Adams,1,2 Dirk Bassler,1 Brian A Darlow,3 Kei Lui,4 Brian Reichman,5 Stellan Hakansson,6 Mikael Norman,7 Shoo K Lee,8 Kjell K Helenius,9 Liisa Lehtonen,10 Laura San Feliciano ,11 Maximo Vento,12 Marco Moroni,13 Marc Beltempo,14 Junmin Yang,8 Prakesh S Shah,8 on behalf of the International Network for EvaluatingOutcomes (iNeo) of Neonates To cite: Adams M, Bassler D, ABSTRACT Strengths and limitations of this study Darlow BA, et al. Preventive Objectives To compare necrotising enterocolitis (NEC) strategies and factors prevention practices and NEC associated factors between ► We report on a large, multinational patient database associated with surgically units from eight countries of the International Network for treated necrotising enterocolitis and high survey response rate, enabling a snapshot Evaluation of Outcomes of Neonates, and to assess their in extremely preterm infants: of contemporary necrotising enterocolitis outcome association with surgical NEC rates. an international unit survey and practices. Design Prospective unit-level survey combined with linked with retrospective cohort ► Survey was completed by a single representative at retrospective cohort study. data analysis. BMJ Open each site rather than all practitioners, whereas re- Setting Neonatal intensive care units in Australia/ 2019;9:e031086. doi:10.1136/ sponses were based on neonatal intensive care unit bmjopen-2019-031086 New Zealand, Canada, Finland, Israel, Spain, Sweden, policies rather than personal opinion.
    [Show full text]
  • Scientific Program Thursday, March 24, 2011 Organizing Committee Itzchak N
    הכינוס†השנתי†ה≠∑¥†של†האיגוד†הישראלי†לנפרולוגיה†ויתר†לחץ†דם ¥≥†עד†∂≥†למרץ†±±∞≥¨†מלון†¢פסטורל¢†כפר†בלום Day 1 Scientific Program Thursday, March 24, 2011 Organizing Committee Itzchak N. Slotki, MD President of ISNH, Head, Division of Adult Nephrology, Shaare Zedek Medical Center, Jerusalem Eliezer Golan, MD President Elect of ISNH, Meir Medical Center, Kfar Saba Scientific Committee Suheir Assady, MD, PhD Chairperson, Director, Department of Nephrology, Rambam Health Care Campus, Haifa Tali Weinstein, MD, PhD Vice President of the ISNH, Sourasky Medical Center, Tel Aviv Eli J. Holzman, MD Director, Nephrology and Hypertension Institute, Chaim Sheba Medical Center, Tel-Hashomer 12.00 – 13.00 Reception & Exhibition 13.00 – 13.25 Session 1 Chair: Suheir Assady, MD, PhD (Hall A) 13.00 – 13.05 Greetings & Opening Remarks Itzchak N. Slotki, MD 13.05 – 13.15 ISNH Registry Eliezer Golan, MD 13.15 – 13.20 In Memorium to Dr. Lazaro Gotloib Avshalom Shostak, MD Head of Nephrology, Haemeq Medical Center 13.20 – 13.25 In memorium to Dr.Ya'akov Garti Shimon Storch, MD Head of Nephrology, Bnai-Zion Medical Center 13.30 – 14.30 Session 2 Chairs: Ze’ev Katzir, MD; Noa Berar-Yanay, MD (Hall A) Free Communications: Clinical Science 1 13.30 Intravenous Iron in Heart Failure Donald S. Silverberg, Adrian Iaina, Doron Schwartz, Dov Wexler. Department of Nephrology and Cardiology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine , Tel Aviv University, Tel Aviv. 13.42 One year's Experience of On-Line Hemodiafiltration: Medical Understandings and Patients' Feelings from Two Northern Israel Dialysis Units Olga Tanchilevsky1 , Noa Berar-Yanay2 , Ronit Geron1, Galina Shkolnik1, Michael Formanov1, Batya Kristal1 1Western Galilee Medical Center, Nahariya, 2Hillel Yaffe Medical Center, Hadera.
    [Show full text]
  • Scientific Program
    Scientific Program 08:00-09:00 Registration, Refreshments, Visit Exhibits 09:00 – 11:00 Plenary Session Hall A Moderators: Prof. Michael Drescher Dr. Ariel Bentancur 09:00-09:20 Greetings Dr. Ariel Bentancur – Conference Chair Prof. Michael Drescher– Chair, Israeli Association of Emergency Medicine 09:20-10:00 Updates and dilemmas on sepsis management 2020 Prof. Nathan Shapiro Professor of Emergency Medicine, Institution Beth Israel Deaconess Medical Center, Department Emergency Medicine, Boston, USA 10:00-10:30 The 2020 know-how of severe pediatric sepsis and septic shock Prof. Santiago Mintegui Pediatric Emergency Department, Cruces University Hospital, Bilbao, Spain 10:30-10:50 Establishing Emergency Medicine in Israel: Reflections and Lessons. Prof. Hezi Waisman, Schneider Children's Hospital מתן פרסים עבור תרומה לקידום רפואה דחופה בישראל 10:50-11:00 11:00-11:30 Break, Refreshments, Visit Exhibits 11:30 – 13:30 Parallel Sessions 11:30 – 13:30 Parallel Session: Pre-Hospital Hall A Moderators: Dr. Avi Benov, Trauma Branch of the IDF Medical Corps Dr. Ariel Eizman, Paramedics School, Magen David Adom 11:30-11:50 Prehospital Pocus מקומו של העל שמע )POCUS( ברפואה דחופה טרם בית חולים ד"ר )PHD( אורן וכט, אוניברסיטת בן גוריון, באר שבע 11:50-12:10 ECPR resuscitation, for whom? החייאת ECPR, מה זה? למי מיועדת? שימוש בטכניקה זו בטרום בית חולים ובמלר"ד ד"ר חגי דקל, מחלקת כירורגיה חזה, המרכז הרפואי וולפסון, חולון 12:10-12:30 Low Titer Group O Whole Blood for Prehospital Casualties עירוי דם מלא במתאר טרום בית חולים ד"ר יעקב חן, צה"ל 12:30-12:50 The Effect of Prehospital Life-Saving Interventions on The Outcome of Severely Injured Patients פעולות מצילות חיים בפצועים קשים במתאר טרום בית חולים ד"ר אלכס סורקין, צה"ל 12:50-13:10 To Intubate or To Save The Patient, That Is the Question לצנרר או להציל את המטופל, זו השאלה ד"ר אבישי צור, צה"ל 13:10-13:30 Post Resuscitation PCI צנתור קורונרי תוך כדי ומיד לאחר החייאה במטופלים שחוו OHCA.
    [Show full text]